글로벌 무침주입 시스템 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

무침 주사 시스템은 약물 투여를 보다 효율적이고 덜 고통스럽게 만들 것을 약속하는 기술을 꾸준히 개발하고 있습니다. 무침 주사 기술을 통해 의사는 바늘로 피부를 뚫지 않고 환자에게 약물을 투여할 수 있습니다. 무침 기술은 환자의 바늘 사용에 대한 불안을 낮추는 것을 포함하여 여러 가지 장점이 있습니다. 무침 주사는 광범위한 약물에 대해 주사기 및 바늘 주사와 매우 효과적이고 생물학적으로 동등합니다. 통증 역치가 낮고 환자가 강력히 선호합니다. 기존 바늘 에 비해 주사가 훨씬 빠르고 바늘 폐기에 어려움이 없습니다. 제약 분야는 제품 판매 증가의 혜택을 볼 뿐만 아니라 투여 요법 및 결과에 대한 준수를 개선할 잠재력도 있습니다.

Data Bridge Market Research는 2021년에 1억 2,400만 달러였던 무침주사 시스템 시장이 2029년까지 4억 6,610만 달러로 급증할 것으로 분석했으며, 2022-2029년 예측 기간 동안 18.0%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

무침 주입 시스템은 바늘로 피부를 뚫지 않고도 환자에게 다양한 약물을 제공하는 혁신적인 접근 방식입니다. 무침 기술은 바늘 사용에 대한 환자의 불안을 최소화한다는 명백한 이점이 있습니다. 무침 주입 기술은 로렌츠, 충격파, 가스 압력 또는 전기영동과 같은 힘을 활용하여 약물을 피부를 통해 추진하는 광범위한 약물 전달 장치를 포함하는 광범위한 개념으로, 피하 주사 바늘의 필요성을 효과적으로 제거합니다.

보고 범위 및 시장 세분화

무침주사 시스템 시장 동향

운전자

• 전 세계적으로 감염병 발병률이 높다

Despite tremendous advancements in sanitation and medicine, infectious illness prevalence remains high over the world. Despite the fact that non-communicable diseases are the leading causes of morbidity and mortality, infectious diseases remain a serious public health concern around the world. According to the National Institute of Allergy and Infectious Diseases, infectious diseases claim the lives of more than 15 million people each year. Despite the fact that non-communicable diseases are the leading causes of morbidity and mortality, infectious diseases remain a serious public health concern around the world. According to the National Institute of Allergy and Infectious Diseases, infectious diseases claim the lives of more than 15 million people each year.

• Growing incidence of transmissible diseases

Most healthcare providers are concerned about needlestick injuries caused by infected needles. Needle stick injuries are most dangerous hazards to people’s health and safety. Because injections are one of the most commonly used procedures for administering pharmaceuticals, healthcare workers are at a high risk of contracting blood-borne diseases through needlestick injuries, which can happen by accident. Every year, some 385,000 health-care workers inadvertently poke themselves with needles, according to the CDC. Needlestick injuries can spread infectious diseases like hepatitis B, hepatitis C, and the human immunodeficiency virus (AIDS) to healthcare workers.

Increase in demand for self-injection devices

Self-injection technologies are a faster and more repeatable technique of providing pharmaceuticals than invasive drug administration methods. Self-injections lower medicine dosage requirements, resulting in improved patient compliance, particularly among the elderly.

• Increased number of technological developments

E- and prescription, and other new technology can assist doctors and pharmacists in a variety of ways, including storing professionals to deliver high-quality, effective medicines. It also helps patients comprehend the majority scheduled proceedings and data and smoothing immunisation progress. Information Technology (IT) has improved safety and patients health, allowing pharmaceutical industry specialists to better understand the effects of their products.

Opportunities

• Increasing demand for biosimilars and immunization procedures

Biosimilars are becoming more widely employed to treat diseases such as cancer, diabetes, hepatitis, anaemia, and a variety of other acute and chronic illnesses. The need for biosimilars is growing in tandem with the rising prevalence of these diseases. There is a substantial opportunity for pharmaceutical and medical device companies to create innovative biosimilar delivery options. Injections are used to provide a variety of biosimilars and vaccines; in this case, needle-free technology provides an easy-to-use and safe method of giving biosimilars without the requirement for a standard injection apparatus or trained people.

• Increasing number of emerging markets

In the future years, the needle-free injection system market in emerging countries is predicted to rise significantly. This is due to an increase in the prevalence of chronic diseases, strong economic growth, and rising purchasing power. The presence of numerous individuals suffering from chronic diseases and the availability of competent labour at a reduced cost characterise growing economies such as India and China.

Restraints/Challenges

• Higher cost of development as associated to conventional injection systems

The complexity of these gadgets increases development expenses. The high cost of units is a result of the significant investment in development, which reduces patient acceptance of these devices. Due to additional associated expenditures such as high infrastructural and personnel costs, the overall development cost of a needle-free injection system is significantly greater.

• Sterilizable needles and conventional needle injections

Needle-free injections, need significant upfront investments and are expected to be more expensive as manufacturers spends more on quality control and device production standards. Needle-free injection starter kits from AdvantaJet, Injex 30, and Medi-Jector cost around USD 165, 260, and 300, respectively. Because needle-free injection devices are more expensive than typical needle injections, their affordability becomes a major challenge.

This needle-free injection system market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the needle-free injection system market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Needle-Free Injection System Market

In the most hopeful scenario, the COVID-19 epidemic has had a favorable impact on the needle-free injection system market as a whole. The COVID-19 pandemic has had a favorable impact on the needle-free injection system market, as the necessity for mass vaccination and self-injectable devices has been a priority since the epidemic began in December 2019. As the number of instances has grown across the globe, the majority of the leading needle-free injection system market players have invested in RandD and formed collaborations and agreements with other industry players and government agencies to create a needle-free injection system for the condition.

Recent Development

• In December 2021, Nykode Therapeutics, a PharmaJet partner, will launch a phase 1/2 clinical study using next-generation DNA-based COVID-19 vaccine candidates. PharmaJet, a company that develops needle-free injection technology, announced today that Nykode Therapeutics (previously Vaccibody), one of its pharmaceutical partners, has started a phase 1/2 clinical trial to address developing SARS-CoV-2 variations. In the clinical trial, the DNA-based vaccinations will be administered intramuscularly only utilizing the PharmaJet Stratis Needle-free Injection System.
• In August 2021, Zydus Cadila, a PharmaJet partner, has received Emergency Use Authorization for the world's first plasmid DNA COVID-19 vaccination delivered via needle-free injection. PharmaJet, a pioneer in needle-free injection technology, said today that Zydus Cadila, one of its partners, has acquired an Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world's first Plasmid DNA Vaccine for COVID-19. The ZyCoV-D vaccination is only available through the PharmaJet Tropis Needle-free Injection System.

Global Needle-Free Injection System Market Scope

The needle-free injection system market is segmented on the basis of type, product, and technology, source of power, usability, delivery site, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Liquid-Based Needle-Free Injectors
• Projectile/Depot-Based Needle-Free Injectors
• Powder-Based Needle-Free Injectors

Product

• Fillable Needle-Free Injectors
• Prefilled Needle-Free Injectors

Technology

• Jet-Based Needle-Free Injectors
• Spring-Based Needle-Free Injectors
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

Source of Power

• Spring-Based Needle-Free Injectors
• Gas Propelled/ Air Forced Injector Systems

Usability

• Disposable Needle-Free Injectors
• Reusable Needle-Free Injectors

Delivery Site

• Subcutaneous Injectors
• Intramuscular Injectors
• Intradermal Injectors

Application

• Vaccine Delivery
• Insulin Delivery
• Oncology
• Pain Management
• Others

End-User

• Hospitals
• Clinics
• Home Care Settings
• Research Laboratories
• Pharmaceutical and Biotechnological Companies
• Others

Needle-Free Injection System Market Regional Analysis/Insights

The needle-free injection system market is analysed and market size insights and trends are provided by country, type, product, technology, source of power, usability, delivery site, application and end-user as referenced above.

The countries covered in the needle-free injection system market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Rising prevalence of chronic diseases such as cancer and diabetes, North America represents the highest share of the worldwide needleless injection system market. Furthermore, the growing desire among patients for self-administration of medications via needle-free injections is propelling the regional market forward.

Due to the increased propensity of patients toward innovative technologies and growing demand for biologics and needle-free injection for self-administration of pharmaceuticals, Asia Pacific is expected to develop rapidly throughout the forecast period 2022-2029. Furthermore, the regional market will benefit from increased investments to reinforce the region's healthcare expenditures, as well as increased research and development operations to produce more modern needle-free methods for proper and effective drug administration.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

무침주사 시스템 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 무침주사 시스템 시장을 위한 다양한 종류의 제품 설치 기반, 라이프라인 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 무침주사 시스템 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 무침주사 시스템 시장 점유율 분석

무침주사 시스템 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 무침주사 시스템 시장과 관련된 회사의 초점에만 관련이 있습니다.

무침주사 시스템 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 안타레스파마(미국)
• INOVIO Pharmaceuticals ( 미국 )
• THE NATIONAL MEDICAL PRODUCTS CO., LTD (사우디 아라비아)
• Valeritas, Inc. (덴마크)
• InsuJet(네덜란드)
• 펜젯(네덜란드)
• 아미코 그룹(UAE)
• 메드이뮨(미국)
• 미스틱제약(미국)
• OptiNose US, Inc. (미국)
• 조게닉스(미국)
• PharmaJet(미국)
• 포털 인스트루먼트(미국)
• Medical International Technology, Inc (MIT) (미국)
• NuGen 의료기기(캐나다)
• 크로스젝트 SA(미국)
• Bioject Medical Technologies (미국)

SKU-47757